Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-034832 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
3,061
Total Value
$72,117.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Feb 2, 2026 | Sale | 3,061 | $23.56 | $72,117.16 | 88,935 | Direct | โ | View Details |